PAPER Lilo E, Wald-Altman S, Solmesky LJ, Ben Yaakov K, Gershoni-Emek N, Bulvik S, Kassis I, Karussis D, Perlson E, Weil M
SEARCH RESULTS
330026 RESULTS
AD Trial Simulation Tool Receives Regulators’ Blessings
RESEARCH NEWS 2013-07-11 Research News Regulatory agencies in the U.S. and Europe have endorsed a quantitative simulation tool that allows researchers to model clinical trials in mild to moderate Alzheimer’s disease. The freely available tool will allow researchers to optimize th
PAPER
Medicine: Stem cells guide Alzheimer's drugs.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Mar;29(2):116-8, 127. PubMed: 23446384PAPER Li YL, Hou Y, Niu C, Yu LX, Cheng YY, Hong Y
[The clinical studies of hyperhomocysteinemia and Alzheimer's disease].
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Mar;29(2):116-8, 127. PubMed: 23833960PAPER Chakrabarti S, Sinha M, Thakurta IG, Banerjee P, Chattopadhyay M
Oxidative Stress and Amyloid Beta Toxicity in Alzheimer's Disease: Intervention in a Complex Relationship by Antioxidants.
Curr Med Chem. 2013 Jun 25; PubMed: 23834172PAPER Weinstein JD, Gonzalez ER, Egleton RD, Hunt DA
A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol.
Consult Pharm. 2013 Jul;28(7):443-54. PubMed: 23835462PAPER Chmielnicki E
Alzheimer's disease: Micrological modulation.
Nat Med. 2013 Jul;19(7):826. PubMed: 23836226PAPER Tsvetkova D, Obreshkova D, Zheleva-Dimitrova D, Saso L
Antioxidant Activity of Galantamine and some of its Derivatives.
Curr Med Chem. 2013 Jun 25; PubMed: 23834167PAPER Andrieux K, Couvreur P
Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.
Ann Pharm Fr. 2013 Jul;71(4):225-33. PubMed: 23835020PAPER Dartigues JF, Foubert-Samier A, Helmer C
[Relationship between educational level and dementia: Social factor and age-related chronic disease].
Rev Epidemiol Sante Publique. 2013 Aug;61 Suppl 3:S195-8. PubMed: 23835147PAPER Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, Garcia PA, Miller BL, Mucke L
Seizures and epileptiform activity in the early stages of Alzheimer disease.
JAMA Neurol. 2013 Sep 1;70(9):1158-66. PubMed: 23835471PAPER Kingwell K
Alzheimer disease: CSF levels of mitochondrial DNA-a new biomarker for preclinical Alzheimer disease?
Nat Rev Neurol. 2013 Aug;9(8):420. PubMed: 23835537PAPER Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA
Genetic susceptibility for Alzheimer disease neuritic plaque pathology.
JAMA Neurol. 2013 Sep 1;70(9):1150-7. PubMed: 23836404PAPER Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, Degroot S, Tapper AR, Sellier C, Charlet-Berguerand N, Karydas A, Seeley WW, Boxer AL, Petrucelli L, Miller BL, Gao FB
Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons.
Acta Neuropathol. 2013 Sep;126(3):385-99. PubMed: 23836290PAPER Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, Maclaughlin R, Walsh C, Al Chalabi A, Hardiman O
Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A Population-Based Case-Control Cohort Study of Familial and Sporadic Amyotrophic Lateral Sclerosis.
Ann Neurol. 2013 Jul 9; PubMed: 23836460Current Filters
No filters selected